Co-treatment with azelinidipine and olmesartan inhibits advanced glycation end products (AGEs) elicited down-regulation of adiponectin mRNA levels in cultured adipocytes partly via its anti-oxidative property.

Cite this paper

@article{Maeda2011CotreatmentWA, title={Co-treatment with azelinidipine and olmesartan inhibits advanced glycation end products (AGEs) elicited down-regulation of adiponectin mRNA levels in cultured adipocytes partly via its anti-oxidative property.}, author={Sayaka Maeda and Takanori Matsui and Masayoshi Takeuchi and Sho-ichi Yamagishi}, journal={International journal of cardiology}, year={2011}, volume={146 2}, pages={264-6} }